BioFluidica Inc.

BioFluidica has invented a ground-breaking diagnostic platform for vastly improved disease detection of cancer and stroke from a simple blood sample.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Chapel Hill, NC, US
  • Currency USD
  • Founded August 2013
  • Employees 6
  • Website biofluidica.com

Company Summary

BioFluidica has developed next generation disease diagnostic platforms. Diagnostic tests include capture and analysis of viable Circulating Tumor Cells, cell free DNA, and exosomes with unprecedented recovery, enabling disease diagnostics from a blood/liquid biopsy. The platform has been clinically validated on 6 cancer types and stroke. The commercial strategy includes a fee for service model as well as instrument and consumable offerings.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free